Bestselling Drugs of 2008

Ranking the best-selling branded drugs in the world is a bit like gathering the most popular kids in high school together in one room. The usual suspects are always there (in this case, that means Lipitor, Plavix, Seroquel, Effexor XR, et al.) until they graduate--or in this case, go off patent. Then they're suddenly missing from the chosen few. So take a close look at this year's crowd, ranked using IMS Health's 2008 sales figures. In some cases, it'll be your last chance. Slideshow

Suggested Articles

Pliant Therapeutics will use the proceeds to push its lead program through midstage trials in fibrotic liver and lung diseases.

Cancer biotech Novellus has struck a deal with Plexxikon for its early- to midstage BRAF-inhibiting hopeful PLX8394.

Chinook Therapeutics is set to merge with fallen Big Pharma darling Aduro Biotech to create a kidney disease player with $180 million in cash.